ā˜°

Kay T. Yeung, Ph.D. - Publications

Affiliations: 
2010 Basic Medical Science New York University, New York, NY, United States 
Area:
Molecular Biology, Cell Biology, Oncology

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Park S, Silva E, Singhal A, Kelly MR, Licon K, Panagiotou I, Fogg C, Fong S, Lee JJY, Zhao X, Bachelder R, Parker BA, Yeung KT, Ideker T. A deep learning model of tumor cell architecture elucidates response and resistance to CDK4/6 inhibitors. Nature Cancer. PMID 38443662 DOI: 10.1038/s43018-024-00740-1  0.32
2024 Sinha S, Farfel A, Luker KE, Parker BA, Yeung KT, Luker GD, Ghosh P. Growth signaling autonomy in circulating tumor cells aids metastatic seeding. Pnas Nexus. 3: pgae014. PMID 38312224 DOI: 10.1093/pnasnexus/pgae014  0.36
2023 Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, Allison KH, Anderson B, Burstein HJ, Chew H, Dang C, Elias AD, Giordano SH, Goetz MP, Goldstein LJ, ... ... Yeung K, et al. NCCN GuidelinesĀ® Insights: Breast Cancer, Version 4.2023. Journal of the National Comprehensive Cancer Network : Jnccn. 21: 594-608. PMID 37308117 DOI: 10.6004/jnccn.2023.0031  0.484
2021 Douglas SR, Yeung KT, Yang J, Blair SL, Cohen O, Eliceiri BP. Identification of CD105+ Extracellular Vesicles as a Candidate Biomarker for Metastatic Breast Cancer. The Journal of Surgical Research. 268: 168-173. PMID 34314883 DOI: 10.1016/j.jss.2021.06.050  0.478
2018 Nakazawa Y, Taniyama Y, Sanada F, Morishita R, Nakamori S, Morimoto K, Yeung KT, Yang J. Periostin blockade overcomes chemoresistance via restricting the expansion of mesenchymal tumor subpopulations in breast cancer. Scientific Reports. 8: 4013. PMID 29507310 DOI: 10.1038/S41598-018-22340-7  0.576
2017 Yeung KT, More S, Woodward B, Velculescu V, Husain H. Circulating Tumor DNA for Mutation Detection and Identification of Mechanisms of Resistance in Non-Small Cell Lung Cancer. Molecular Diagnosis & Therapy. PMID 28337711 DOI: 10.1007/S40291-017-0260-5  0.378
2017 Yeung KT, Yang J. Epithelial-mesenchymal transition in tumor metastasis. Molecular Oncology. 11: 28-39. PMID 28085222 DOI: 10.1002/1878-0261.12017  0.449
2017 Jung H, Yeung KT, Lee T, Tsai JH, Yang J. Abstract 3052: Defining the role of EMT in breast cancer dormancy and metastasisin vivo Cancer Research. 77: 3052-3052. DOI: 10.1158/1538-7445.Am2017-3052  0.539
2014 Das S, Yeung KT, Mahajan MA, Samuels HH. Fas Activated Serine-Threonine Kinase Domains 2 (FASTKD2) mediates apoptosis of breast and prostate cancer cells through its novel FAST2 domain. Bmc Cancer. 14: 852. PMID 25409762 DOI: 10.1186/1471-2407-14-852  0.612
2011 Yeung KT, Das S, Zhang J, Lomniczi A, Ojeda SR, Xu CF, Neubert TA, Samuels HH. A novel transcription complex that selectively modulates apoptosis of breast cancer cells through regulation of FASTKD2. Molecular and Cellular Biology. 31: 2287-98. PMID 21444724 DOI: 10.1128/Mcb.01381-10  0.629
2009 Tinnikov AA, Yeung KT, Das S, Samuels HH. Identification of a novel pathway that selectively modulates apoptosis of breast cancer cells. Cancer Research. 69: 1375-82. PMID 19190336 DOI: 10.1158/0008-5472.Can-08-2896  0.63
Show low-probability matches.